PINK

Simplify Health Care ETF

Spotlight Banner
as of 05/20/2022

NAV

$ 24.93

NAV Change

+ $ 0.32 /1.30%

Price

$ 24.91

Price Change

+ $ 0.33 /1.34%

The Simplify Health Care ETF (PINK) seeks long term capital appreciation by providing investors with multi-cap exposure to groundbreaking and innovative companies in biotech, medtech, gene therapy, and other fast growing health care related sectors.

Michael Taylor serves as lead portfolio manager of the ETF and brings over two decades of experience managing long/short health care equity portfolios at leading hedge funds. PINK is the first 100% pro bono ETF focused on the health care sector and net profits will be donated for the benefit of the Susan G. Komen foundation on an annual basis.

PINK: Shares for the Cure Find out more.

Benefiting Susan G. Komen logo
Spotlight Banner

Documents

View Research Tools

Fund Overview

As of 05/20/2022

Ticker Symbol
PINK
Gross Expense Ratio
0.50%
CUSIP
82889N772
Total Assets
$38,649,040.70
Shares Outstanding
1,550,001
SEC 30-Day Yield as of 04/30/2022
0.35%
Distribution Frequency
Quarterly
Options Available
No
Inception Date
10/07/2021
Premium/Discount (%) as of 05/20/2022
-0.10%
NAV
$24.93
NAV Per Share as of 05/20/2022
$24.93
Market Price as of 05/20/2022
$24.91
30-Day Median Bid-Ask Spread
0.16%
Bid/Ask
$24.90/$24.96
Midpoint Price
$24.93
Volume
25,113
NAV Symbol
PINK.NV
IOPV Symbol
PINK.IV
Shares Out. Symbol
PINK.SO

Management Fees

This table describes the fees and expenses that you may pay if you buy, sell, and hold shares of the Fund. Investors purchasing or selling shares of the Fund in the secondary market may be subject to costs (including customary brokerage commissions) charged by their broker. The fee table located in the prospectus and updates in prospectus supplements prevail.

Annual Fund Operating Expenses (expenses that you pay each year as a percentage of the value of your investment)
Management Fees 0.50%
Distribution and Service (12b-1) Fees 0.00%
Other Expenses1 0.00%
Interest Expense 0.00%
Acquired Fund Fees and Expenses2 0.00%
Total Annual Fund Operating Expenses 0.50%
1. Other Expenses are estimated for the Fund’s initial fiscal year.

2. Acquired Fund Fees and Expenses, which are estimated for the Fund’s initial fiscal year, are the indirect costs of investing in other investment companies. The operating expenses in this fee table will not correlate to the expense ratio in the Fund’s financial highlights located in the prospectus because the financial statements include only the direct operating expenses incurred by the Fund.

Fund Performance

As of 04/30/2022 03/31/2022

Monthly Quarterly
Cumulative 1 Month 3 Month 6 Month 1 Year Since Inception
NAV -5.81% 1.06% -2.94% — 2.33%
Market Price -5.90% 1.16% -3.02% — 2.63%
Cumulative 1 Year 3 Year Since Inception
NAV — — —
Market Price — — —
Cumulative 1 Year Since Inception
NAV — 8.65%
Market Price — 9.06%
Cumulative 1 Year 3 Year 5 Year Since Inception
NAV — — — —
Market Price — — — —
The performance data quoted represents past performance and is no guarantee of future results. Current performance may be lower or higher than the performance data quoted. Investment returns and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance data for the most recent month-end is available above.

NAV: The dollar value of a single share, based on the value of the underlying assets of the fund minus its liabilities, divided by the number of shares outstanding. Calculated at the end of each business day.

Market Price: The current price at which shares are bought and sold. Market returns are based upon the last trade price.

Historical Premium/Discount

Calendar Year 2021 1st Quarter of 2022
Days Traded at Premium
40
19
Days Traded at Discount
19
43
The above frequency distribution chart presents information about the difference between the daily market price for shares of the Fund and the Fund's reported Net Asset Value. The amount that the Fund's market price is above the reported NAV is called the premium. The amount that the Fund's market price is below the reported NAV is called the discount. The market price is determined using the midpoint between the highest bid and the lowest offer on the listing exchange, as of the time that the Fund's NAV is calculated (usually 4:00 p.m. EST). The horizontal axis of the chart shows the premium or discount expressed in basis points. The vertical axis indicates the number of trading days in the period covered by the chart. Each bar in the chart shows the number of trading days in which the Fund traded within the premium/discount range indicated.
Ticker Name Quantity Weight
UNH United Health Group Inc. 7913 9.94%
JNJ Johnson & Johnson 13422 6.11%
CI Cigna Corp 7734 5.19%
CNC CENTENE CORP DEL 22227 4.89%
ANTM ANTHEM INC USD 0.01 3162 4.03%
LNTH LANTHEUS HLDGS INC USD 0.01 25018 4.03%
SYK Stryker Corp. 6696 4.02%
LLY Lilly (Eli) & Co. 5146 3.98%
MCK McKesson Corp. (New) 4364 3.65%
HZNP HORIZON THERAPEUTICS PLC 14833 3.47%
HUM Humana Inc. 2840 3.23%
HCA HCA HLDGS INC USD 0.01 5798 3.07%
UTHR United Therapeutics Corp 6132 2.99%
ISRG Intuitive Surgical Inc. 4901 2.78%
ILMN Illumina Inc 4273 2.69%
PFE Pfizer, Inc. 19706 2.68%
THC Tenet Healthcare Corp. 14208 2.37%
ABT Abbott Labs 7769 2.28%
TMO Thermo Fisher Scientific Inc 1364 1.96%
ABBV ABBVIE INC USD 0.01 4103 1.60%
LIVN LIVANOVA PLC GBP 1.0 9500 1.59%
CVS CVS/Caremark Corp. 6442 1.58%
LH Laboratory Corp. of America Holding 2459 1.58%
BDX Becton, Dickinson 2418 1.58%
VRAY ViewRay Inc 195802 1.51%
MDT MEDTRONIC PLC 5232 1.39%
RMD ResMed Inc. 2381 1.22%
IQV IQVIA Holdings Inc 2046 1.07%
COO The Cooper Companies 1201 1.06%
WAT Waters Corporation 1116 0.92%
ATRC AtriCure Inc 8113 0.92%
BAX Baxter International Inc. 4836 0.92%
BSX Boston Scientific Corp. 8216 0.83%
A Agilent Technologies 2542 0.82%
TECH BIO-TECHNE CORP 806 0.76%
DXCM DEXCOM INC USD 0.001 884 0.73%
QDEL Quidel Corp 2730 0.71%
SWAV Shockwave Medical Inc 1475 0.60%
AMGN Amgen 934 0.60%
GILD Gilead Sciences 3037 0.50%
ZTS ZOETIS INC USD 0.01 1011 0.43%
SGEN SEAGEN INC NPV 1116 0.40%
ALNY Alnylam Pharmaceuticals Inc 992 0.34%
VRTX Vertex Pharmaceuticals 498 0.33%
PODD INSULET CORP USD 0.001 623 0.32%
DHR Danaher Corp. 455 0.30%
VEEV Veeva Systems Inc 682 0.29%
STE STERIS PLC USD 75.0 496 0.29%
HSIC Schein (Henry) Inc. 1240 0.27%
PKI PerkinElmer Inc 558 0.21%
MTD Mettler-Toledo Intl 62 0.20%
EW Edwards Lifesciences Corp 599 0.15%
ALGN Align Technology Inc 142 0.10%
IDXX IDEXX Laboratories 82 0.08%
EMBC Embecta Corp 487 0.03%
- Estimated Cash 155351 0.40%

Holdings are subject to change without notice.

Recent Distributions

Ex-Dividend Date Record Date Payable Date Ordinary Income Short Term Capital Gains Long Term Capital Gains Return of Capital Total Distribution
$0.03535 $0.00000 $0.00000 $0.00000 $0.03535
$0.01170 $0.00000 $0.00000 $0.00000 $0.01170
View Distribution History